Insider Trading & Ownership - Foresite Capital Fund IV, L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Foresite Capital Fund IV, L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-08
Purchase
2023-05-10
5:42 pm
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
1,780,000$2.8$4,984,00010,192,354
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-04-03
Disposition
2024-04-05
2:15 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
13,718,311$00
(Indirect)
View
2023-02-17
Other
2023-02-22
2:49 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Fund V L.P.
Foresite Capital Management V LLC
Foresite Capital Opportunity Fund V L.P.
Foresite Capital Opportunity Management V LLC
10% Owner
1,100,000$013,038,311
(Indirect)
View
2021-11-01
Other
2021-11-03
4:17 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
1,963,180$06,628,733
(Indirect)
View

Ownership
2021-02-10
6:00 pm
N/A
N/A
Aclaris Therapeutics Inc.ACRSForesite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
0$06,612,181
(Indirect)
View
2020-12-07
Conversion
2020-12-09
1:35 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
19,675,448$0291,667
(Indirect)
View
2020-12-03
Option Award
2020-12-04
8:57 pm
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
1,000,000$20125,000
(Indirect)
View

Ownership
2020-12-03
06:03 am
N/A
N/A
Kinnate Biopharma Inc.KNTEForesite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Foresite Capital Opportunity Management V LLC
Foresite Capital Opportunity Fund V L.P.
10% Owner
0$09,838,311
(Indirect)
View